{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:27Z","timestamp":1786119207518,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/iae.0b013e3181706302","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:39:15Z","timestamp":1236263955000},"page":"964-968","source":"Crossref","is-referenced-by-count":65,"title":["Treatment of Radiation Maculopathy With Intravitreal Injection of Bevacizumab (Avastin)"],"prefix":"10.1097","volume":"28","author":[{"given":"Aanchal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Muecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(92)31832-9","article-title":"Radiation maculopathy after proton beam irradiation for choroidal melanoma.","volume":"99","author":"Guyer","year":"1992","journal-title":"Ophthalmology"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90277-3","article-title":"High intensity 125 iodine plaque treatment of uveal melanoma.","volume":"26","author":"Quivey","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-7-20210130","first-page":"229","article-title":"Maculopathy caused by irradiation in patients treated for choroid melanoma.","volume":"4","author":"Haye","year":"1990","journal-title":"Ophtalmologie"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(98)98023-X","article-title":"The efficacy of focal laser therapy in radiation-induced macular edema.","volume":"105","author":"Hykin","year":"1998","journal-title":"Ophthalmology"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.eye.6701637","article-title":"Photodynamic therapy for maculopathy due to radiation retinopathy.","volume":"19","author":"Bakri","year":"2005","journal-title":"Eye"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006982-200110000-00026","article-title":"Radiation retinopathy: the role of pentoxifylline.","volume":"21","author":"Gupta","year":"2001","journal-title":"Retina"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.81.2.154","article-title":"Increased expression of angiogenic growth factors in age-related maculopathy.","volume":"81","author":"Kliffen","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.","volume":"26","author":"Haritglou","year":"2006","journal-title":"Retina"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","article-title":"Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.","volume":"26","author":"Mason","year":"2006","journal-title":"Retina"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajo.2006.09.014","article-title":"Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy.","volume":"143","author":"Finger","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ophtha.2005.01.043","article-title":"Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.","volume":"112","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmology"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","article-title":"Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.","volume":"143","author":"Peters","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2337\/diabetes.47.12.1953","article-title":"Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.","volume":"47","author":"Antonetti","year":"1998","journal-title":"Diabetes"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1167\/iovs.06-0322","article-title":"VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.","volume":"47","author":"Harhaj","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/IAE.0b013e31806e6042","article-title":"Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.","volume":"27","author":"Mason","year":"2007","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200807000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:54Z","timestamp":1786038534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200807000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181706302","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}